Search
Search Results
##search.searchResults.foundPlural##
-
CHLORAMBUCIL PLUS RITUXIMAB AS FRONT-LINE THERAPY IN ELDERLY/UNFIT PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS OF A SINGLE-CENTRE EXPERIENCE.
3163PDF: 896HTML: 1533Fig.1 CHL-R paper: 214Fig 2 CHL-R paper: 237 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4095PDF: 1584HTML: 944 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3224PDF: 1008HTML: 2023 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2644PDF: 1074HTML: 116 -
THE IMPACT OF HUMAN PLATELET ANTIGEN ALLELE ON ANTIPLATELET ANTIBODIES AND CRYOGLOBULINS IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA AND HEPATITIS C VIRUS-ASSOCIATED IMMUNE THROMBOCYTOPENIA Human platelet antigen and immune thrombocytopenia
1009PDF: 861Suppl. Files: 456HTML: 286 -
PARASITIC INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
3679PDF: 1236HTML: 3886Untitled: 211Untitled: 258 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4484PDF: 1916HTML: 17735 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1599PDF: 797HTML: 1231Figure 1: 172Figure 2: 187Figure 3: 183 -
-
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
719PDF: 464HTML: 6265 -
A HEALTH RELATED QUALITY OF LIFE AND PSYCHOPATHOLOGICAL SYMPTOMS IN PEOPLE WITH HEMOPHILIA, BLOODBORNE CO-INFECTIONS AND COMORBIDITIES: AN ITALIAN MULTICENTER OBSERVATIONAL STUDY PSYCHOLOGICAL DINAMICS OF A GROUP OF ITALIAN HEMOPHILIACS WITH AND WITHOUT (CO)INFECTIONS AND COMORBIDITIES: A MULTICENTER STUDY
1430PDF: 1207HTML: 500 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3870PDF: 1470HTML: 8513 -
PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS
1752PDF: 876HTML: 373Fig1: 231Fig.2: 251Fig. 3: 181Fig. 5: 195Fig. 4: 223 -
Cardiac toxicity associated with HCV direct antiviral agents Heart in HCV DAAs therapy
1583PDF: 972HTML: 187 -
END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRASFUSION DEPENDEND-β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATION Challenges in Supportive Care, Equity, and Compassion at End of Life
992PDF: 656Html: 156 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2602PDF: 1605HTML: 2354Table1: 190 -
Parvovirus B19-triggered acute hemolytic anemia and thrombocytopenia in a child with Evans syndrome
3524PDF: 983HTML: 425Table 1.: 226 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12340PDF: 1678HTML: 4169Cover letter: 197Figure 1: 204 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1565PDF: 845HTML: 1031Picture 1: 168 -
Hypophosphatemic osteomalacia associated with tenofovir: a multidisciplinary approach is required.
1341PDF: 830HTML: 10050cover letter to the editor: 165tile page: 247 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1382PDF: 816HTML: 3121 -
GLUCOSE HOMEOSTASIS AND ΑSSESSMENT OF Β-CELL FUNCTION BY 3-HOUR ORAL GLUCOSE TOLERANCE (OGTT) IN PATIENTS WITH Β-THALASSEMIA MAJOR WITH SERUM FERRITIN BELOW 1,000 NG/DL: RESULTS FROM A SINGLE ICET-A CENTRE OGTT in thalassemia and iron overload
3906PDF: 1096HTML: 431







